IL-1β, but not IL-1α, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses

作者: Aya Nambu , Susumu Nakae , Yoichiro Iwakura

DOI: 10.1093/INTIMM/DXL007

关键词:

摘要: As IL-1 expression is augmented in delayed-type hypersensitivity (DTH) responses, we analyzed the role of this response. DTH responses against methyl BSA (mBSA) were significantly suppressed IL-1b-deficient (IL-1b � /� ) and IL-1a/b mice, but not IL-1a mice. In contrast, IL-1R antagonist (IL-1Ra mice exacerbated. Lymph node cells derived from mBSA-sensitized IL-1b ,I L-1a/b type I (IL-1RI) exhibited reduced proliferative mBSA, while these IL-1Ra demonstrated responses. wild-type following adoptive transfer CD4 1 T also reduced, those given IL-Ra increased. IL-1RI , upon transplantation The recall response mBSA decreased co-culture with dendritic (DCs) normal DCs tumor necrosis factor a (TNF suppressed; magnitude suppression TNF however, was similar to that observed These observations indicate possesses dual functions during necessary for efficient priming cells. addition, cell-derived plays an important activation elicitation phase, resulting production TNF, activate allergen-specific

参考文章(60)
Takayuki Yoshimoto, Chrong-Reen Wang, Toshihiko Yoneto, Akio Matsuzawa, William W. Cruikshank, Hideo Nariuchi, Role of IL-16 in delayed-type hypersensitivity reaction. Blood. ,vol. 95, pp. 2869- 2874 ,(2000) , 10.1182/BLOOD.V95.9.2869.009K18_2869_2874
Walter Newman, Jeffrey S. Warren, Michael K. Mansour, Michelle L. Rand, Douglas J. Ringler, Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1 American Journal of Pathology. ,vol. 148, pp. 855- 864 ,(1996)
Siemion Iz, Wieczorek Z, Kluczyk A, Słoń-Usakiewicz Jj, IMMUNOMODULATORY ACTIVITY OF OLIGOPEPTIDES RELATED TO INTERLEUKIN 1 RECEPTOR ANTAGONIST SEQUENCE Archivum Immunologiae Et Therapiae Experimentalis. ,vol. 45, pp. 427- 433 ,(1997)
K L Stocking, P J Morrissey, C R Willis, K Charrier, M B Glaccum, J J Peschon, D J Livingston, C Maliszewski, J L Smith, Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. Journal of Immunology. ,vol. 159, pp. 3364- 3371 ,(1997)
Taniguchi T, Sekikawa K, Momotani E, Ikeda A, Takata M, Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α-deficient mice Laboratory Investigation. ,vol. 77, pp. 647- 658 ,(1997)
Susumu Nakae, Masahide Asano, Reiko Horai, Nobuo Sakaguchi, Yoichiro Iwakura, IL-1 Enhances T Cell-Dependent Antibody Production Through Induction of CD40 Ligand and OX40 on T Cells Journal of Immunology. ,vol. 167, pp. 90- 97 ,(2001) , 10.4049/JIMMUNOL.167.1.90
L Mori, G De Libero, W Lesslauer, S Iselin, Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. Journal of Immunology. ,vol. 157, pp. 3178- 3182 ,(1996)
L M Nadler, J Segil, A S Freedman, J Daley, G Freeman, J Whitman, Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. Journal of Immunology. ,vol. 141, pp. 3398- 3404 ,(1988)
Xiaoping Song, Elena Voronov, Tatyana Dvorkin, Eyal Fima, Emanuela Cagnano, Daniel Benharroch, Yaakov Shendler, Olle Bjorkdahl, Shraga Segal, Charles A. Dinarello, Ron N. Apte, Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. Journal of Immunology. ,vol. 171, pp. 6448- 6456 ,(2003) , 10.4049/JIMMUNOL.171.12.6448